Motif BioSciences' IPO

Motif BioSciences raised a round of funding on March 20, 2015. Investors include Public.

Motif BioSciences is developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. Motif has a lead antibiotic candidat…

Articles about Motif BioSciences' IPO: